Latham & Watkins LLP represented SQZ Biotechnologies Company in the transaction. Goodwin Procter LLP advised the underwriters on the deal. SQZ Biotechnologies Company (NYSE: SQZ) (“SQZ”)…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
